Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,635
Total Claims
$1.3M
Drug Cost
188
Beneficiaries
$7,121
Cost/Patient
Risk Score Breakdown 38/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+674%
Opioid rate vs peers
48.6% vs 6.3% avg
-48%
Cost per patient vs peers
$7,121 vs $14K avg
-18%
Brand preference vs peers
11.9% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 674% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
48.6%
Opioid Rate
794
Opioid Claims
$16K
Opioid Cost
12.0%
Long-Acting Rate
This provider's opioid prescribing rate of 48.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 195 claims · $1.3M
Generic: 1,440 claims · $79K
Patient Profile
68
Avg Age
64%
Female
3.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About